054 A Selective Tyrosine Kinase 2 Inhibitor, BMS-986165, Decreases the Transcriptional Signature of Th17, Interleukin-12, and Interferon Pathways in Skin of Psoriasis: Results From a Phase 2 Trial

Subjects

Subjects :

Chemistry
Cell Biology
Dermatology
medicine.disease
Biochemistry
Interferon
Tyrosine kinase 2
Psoriasis
Phase (matter)
medicine
Cancer research
Interleukin 12
Molecular Biology
medicine.drug

Details

ISSN :

0022202X

Volume :

139

Database :

OpenAIRE

Journal :

Journal of Investigative Dermatology

Accession number :

edsair.doi...........98c36f3223af2073f4f40072cf25d43c